Each year at The MedTech Conference, AdvaMed is dedicated to offering outstanding opportunities for the entire medtech ecosystem and this year is no exception! Our cross-cutting program covers dozens of key issues – from M&A to regulatory affairs and compliance best practices, to digital technologies and DEI… there’s something for everyone.
Join us in Toronto October 15-17 for an action-packed week with a dynamic program that promises to deliver timely insights and connect you with the subject matter experts that help keep patients in motion. Register by August 13 to ensure you are featured on our attendee list.
10 New #MTC24 Sessions Just Announced:
1. The Funding Gap for MedTech Innovations and the Role of Strategic Investors
Moderator: Amy Siegel, CEO & Co-Founder, S2N Health
– Lori Chmura, CEO, Nyra Medical
– Virginia Giddings, VP, Exploration, Edwards LifeSciences
– Gwen Watanabe, Managing Director, H.I.G. Capital
– Cynthia Yee, Partner, Vensana Capital
2. Investment Landscape for Diagnostic Testing: Perspectives of Manufacturers, Laboratories and Venture Capital
Moderator: Jennifer Leib, Founder, Innovation Policy Solutions
– Jim Almas, VP & National Medical Director for Clinical Effectiveness, LabCorp
– Ken Bahk, CEO, Lakewood Holdings Deborah Godes, Vice President, McDermott+ Consulting
3. Immersive Therapeutics: Bringing Regulated XR Applications from the Lab into the Real World
Moderator: Jithesh Veetil, Senior Program Director, MDIC
– Diane Gromala, Distinguished Professor, School of Interactive Arts and Technology (SIAT), Simon Fraser University
– Jessica Paulsen, Associate Director for Digital Health, FDA Invited
– Josh Sackman, President and Cofounder, AppliedVR
– Scott Xiao, CEO and Co-founder, Luminopia
4. How MedTech is Helping Reduce Patient Backlog in Canada
Moderator: Patrick Daly, Global Vice President for MedTech Market Measurement, IQVIA MedTech
– James Brodie, General Manager, Canada, Johnson & Johnson MedTech
– Nicole DeKort, CEO, Medtech Canada
– Sylvia Jones, Minister of Health, Province of Ontario, Minister of Health, Province of Ontario Invited
5. Unlocking Health Data: Navigating Legal Landmines for Innovation
Moderator: Matt McDonell, Global Privacy Officer, Zimmer Biomet
– David Peloquin, Partner, ROPES & GRAY LLP
– Rebecca Perez-Serrano, Vice President, Chief Privacy Officer, ResMed
– Thomas Schumacher, VP Chief Legal Counsel, Data and Privacy, Medtronic, Plc
6. Chief Compliance Officer Lightning Round: Top Compliance Concerns for MedTech Business Leaders
Moderators: Matthew Wetzel, Partner, Life Sciences Regulatory & Compliance; Greg Demske, Partner, Goodwin Procter LLP
– Jonelle Burnham, General Counsel & Chief Compliance Officer, CVRx
– Sujata Dayal, Member, Board of Directors, Emergent
– Kate Godfrey, Vice President, Chief Compliance Officer, America, KARL STORZ Endoscopy- America, Inc.
– Rebecca Orttel, Vice President, Chief Ethics and Compliance Officer for the Operating Units, Medtronic
7.Navigating the Intersection: Digital Health Innovations and Market Access Strategies
Moderator: Amy Palatiello, Reimbursement Director, Medtronic
– Jason Bennett, Director, Technology, Coding, and Pricing Group, CMS Invited
– Zach Hochstetler, VP, Coding & Reimbursement, AMA Robert Jarrin, Consultant, ResMed/DMPAG
8. CMS’s Goldilocks Dilemma With CED: Getting Their Coverage with Evidence Development Policy Just Right
Moderator: Barry Liden, Director, Public Policy, USC Schaeffer Center
– Peter Boyd, EVP of Business Development and General Counsel, ReGelTec
– Perry Bridger, Senior Advisor, Public Affairs, Edwards Lifesciences
– Steven Farmer, Chief Strategy Officer for Coverage, CMS Invited
– Sue Peschin, CEO, Alliance for Aging Research
9. Making Real-World Evidence a “Real-World” Practice
Moderator: Heather Colvin, Director, Evidence and Outcomes Policy, Johnson & Johnson Medtech
– Daniel Canos, Director, OCEA, FDA Invited
– Katharine Cresswell, Scientific Adviser – Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE)
– Diane Francis, Vice President, Global Health Economics & Reimbursement, Transcatheter Mitral & Tricuspid Therapies, Edwards Lifesciences
10. Is China+1 a Quality Opportunity or Threat for Medical Device Manufacturers?
Moderator: Ravi Nabar, Senior VP, QARA, Compliance Group
– Ranjeet Banerjee, CEO, Cold Chain Technologies
– Garth Conrad, Vice President, Flex Medical Arnav Dey, Partner, McKinsey and Company
– Manju Parkhs, Senior Executive, Molex We’re about one week away from our 2024 program announcement, so stay tuned for the full agenda, and be sure to register before Tuesday, August 13 to save on your all-access pass!
